Gujarat, India

Shubhashchandra Shailendra Mandge

This inventor holds 1 USPTO granted patent. Top assignee: Cadila Healthcare Limited. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shubhashchandra Shailendra Mandge. Retrieved from https://idiyas.com/inventor/shubhashchandra-shailendra-mandge

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shubhashchandra Shailendra Mandge: Innovator in Pharmaceutical Compositions

Introduction

Shubhashchandra Shailendra Mandge is a notable inventor based in Gujarat, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable solid pharmaceutical matrix compositions.

Latest Patents

His most recent patent is titled "Stable solid pharmaceutical matrix compositions of sirolimus." This invention discloses a stable solid pharmaceutical matrix composition comprising sirolimus or pharmaceutically acceptable salts thereof along with one or more sugars. This innovation is crucial for enhancing the stability and efficacy of pharmaceutical formulations.

Career Highlights

Shubhashchandra is currently associated with Cadila Healthcare Limited, a prominent player in the pharmaceutical industry. His work at Cadila Healthcare has allowed him to focus on innovative solutions that address critical healthcare needs.

Collaborations

He has collaborated with esteemed colleagues such as Sunilendu Bhushan Roy and Sushrut Krishnaji Kulkarni. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical technologies.

Conclusion

Shubhashchandra Shailendra Mandge's contributions to pharmaceutical innovations exemplify the importance of research and development in healthcare. His work continues to impact the industry positively, paving the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…